Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ES-481 in Drug Resistant Epilepsy
NCT04714996Phase 2Unknown
- Sponsor
- ES Therapeutics LLC
- Start
- Oct 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of es-481 in epilepsy, sponsored by ES Therapeutics LLC. Status: unknown.
02
Drugs
es-481
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04714996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04714996.